Growth Metrics

Sarepta Therapeutics (SRPT) Short term Debt (2010 - 2025)

Sarepta Therapeutics' quarterly Short term Debt came in at $36.0 million in Q3 2025, down 60.7% year-on-year from $91.6 million in Q3 2024, and down 60.7% quarter-over-quarter from $91.6 million in Q3 2024.

Sarepta Therapeutics has reported Short term Debt for 12 years, with the latest figure at $36.0 million in Q3 2025.

  • For the quarter ending Q3 2025, Short term Debt fell 60.7% year-over-year to $36.0 million; the trailing twelve-month figure through Sep 2025 stood at $36.0 million (down 60.7% YoY), and the FY2023 full-year result was $105.5 million, changed N/A from the prior year.
  • Short term Debt for Q3 2025 stood at $36.0 million, down from $91.6 million in the prior quarter.
  • The five-year high for Short term Debt was $105.6 million in Q1 2024, with the low at $36.0 million in Q3 2025.
  • Average Short term Debt over 3 years is $86.0 million, with a median of $91.6 million recorded in 2024.
  • Peak annual rise in Short term Debt reached 60.7% in 2025, while the deepest fall reached 60.7% in 2025.
  • Tracing SRPT's Short term Debt over 3 years: stood at $105.5 million in 2023, then retreated by 13.17% to $91.6 million in 2024, then tumbled by 60.7% to $36.0 million in 2025.
  • The last three Short term Debt figures came in at $36.0 million (Q3 2025), $91.6 million (Q3 2024), and $91.5 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 36.00 Mn
Sep 30, 2024 91.60 Mn
Jun 30, 2024 91.51 Mn
Mar 31, 2024 105.59 Mn
Dec 31, 2023 105.48 Mn
Jun 30, 2018 9.51 Mn
Mar 31, 2018 3.45 Mn
Dec 31, 2017 6.18 Mn
Sep 30, 2017 4.73 Mn
Jun 30, 2017 11.22 Mn
Mar 31, 2017 11.35 Mn
Dec 31, 2016 10.11 Mn
Sep 30, 2016 10.11 Mn
Jun 30, 2016 10.11 Mn
Mar 31, 2016 7.60 Mn
Dec 31, 2015 5.94 Mn
Sep 30, 2015 3.44 Mn
Jun 30, 2015 100,000.00
Mar 31, 2015 99,000.00
Dec 31, 2014 98,000.00
Sep 30, 2014 97,000.00
Jun 30, 2014 96,000.00
Mar 31, 2014 94,000.00
Dec 31, 2013 9.01 Mn
Sep 30, 2013 35.99 Mn
Jun 30, 2013 90,000.00
Mar 31, 2013 90,000.00
Dec 31, 2012 89,000.00
Mar 31, 2012 86,000.00
Dec 31, 2011 85,000.00
Sep 30, 2011 84,000.00
Jun 30, 2011 83,000.00
Dec 31, 2010 81,000.00